chrX-16832725-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_018360.3(TXLNG):ā€‹c.967C>Gā€‹(p.Gln323Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000922 in 1,193,129 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000018 ( 0 hom., 1 hem., cov: 24)
Exomes š‘“: 0.0000083 ( 0 hom. 4 hem. )

Consequence

TXLNG
NM_018360.3 missense

Scores

1
3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.44
Variant links:
Genes affected
TXLNG (HGNC:18578): (taxilin gamma) This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15574032).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TXLNGNM_018360.3 linkuse as main transcriptc.967C>G p.Gln323Glu missense_variant 6/10 ENST00000380122.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TXLNGENST00000380122.10 linkuse as main transcriptc.967C>G p.Gln323Glu missense_variant 6/101 NM_018360.3 P1Q9NUQ3-1
TXLNGENST00000398155.4 linkuse as main transcriptc.571C>G p.Gln191Glu missense_variant 4/81 Q9NUQ3-2

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111736
Hom.:
0
Cov.:
24
AF XY:
0.0000294
AC XY:
1
AN XY:
34032
show subpopulations
Gnomad AFR
AF:
0.0000325
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000204
AC:
3
AN:
147057
Hom.:
0
AF XY:
0.0000215
AC XY:
1
AN XY:
46537
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000928
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000145
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000832
AC:
9
AN:
1081393
Hom.:
0
Cov.:
30
AF XY:
0.0000114
AC XY:
4
AN XY:
351327
show subpopulations
Gnomad4 AFR exome
AF:
0.0000388
Gnomad4 AMR exome
AF:
0.0000897
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000599
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111736
Hom.:
0
Cov.:
24
AF XY:
0.0000294
AC XY:
1
AN XY:
34032
show subpopulations
Gnomad4 AFR
AF:
0.0000325
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 01, 2024The c.967C>G (p.Q323E) alteration is located in exon 6 (coding exon 6) of the TXLNG gene. This alteration results from a C to G substitution at nucleotide position 967, causing the glutamine (Q) at amino acid position 323 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.61
CADD
Uncertain
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.082
T;.
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.82
T;T
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.6
N;N
REVEL
Benign
0.12
Sift
Benign
0.22
T;T
Sift4G
Benign
0.16
T;T
Polyphen
0.39
B;B
Vest4
0.15
MVP
0.26
MPC
0.37
ClinPred
0.15
T
GERP RS
5.3
Varity_R
0.64
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371717188; hg19: chrX-16850848; API